Table of Contents for the Digital Edition of Drug Information Journal - September 2007 Table of Contents Biomarker Editorial: The Many Lives of the Biomarker Implementation of a Biomarker Into Drug Development: Example of Identifying the Right Imaging “Tool” for an Oncology Study Imaging Biomarker Applications in Oncology Drug Development Molecular Biomarkers A Regulatory Perspective on Validation of Surrogate Endpoints Interrater Reliability for Multiple Raters in Clinical Trials of Ordinal Scale Notes on Test Equality in Stratified Noncompliance Randomized Trials Sex Differences in QT Interval Variability and Implication on Sample Size of Thorough QT Study Some Comments on Improving Collaboration Skills of the Statistician on a Drug Development Team Using Data Mining to Predict Safety Actions From FDA Adverse Event Reporting System Data The Demographic, Practice, and Prescribing Characteristics of US Clinical Investigators The December Effect in FDA Drug Approvals: Assessing the Submissions Echo Hypothesis Development of an Established Name: Analyzing Stem Based United States Adopted Naming How to Improve Complex Drug Development? A Critical Review of FDA Advisory Meetings A Statistician’s Viewpoint of Responders in the Treatment of Neuropathic Pain Drug Information Journal - September 2007 Drug Information Journal - September 2007 - (Page Intro) Drug Information Journal - September 2007 - (Page Cover1) Drug Information Journal - September 2007 - (Page Cover2) Drug Information Journal - September 2007 - (Page i) Drug Information Journal - September 2007 - (Page ii) Drug Information Journal - September 2007 - (Page iii) Drug Information Journal - September 2007 - (Page iv) Drug Information Journal - September 2007 - (Page v) Drug Information Journal - September 2007 - (Page vi) Drug Information Journal - September 2007 - Table of Contents (Page vii) Drug Information Journal - September 2007 - Table of Contents (Page viii) Drug Information Journal - September 2007 - Table of Contents (Page ix) Drug Information Journal - September 2007 - Table of Contents (Page x) Drug Information Journal - September 2007 - Table of Contents (Page xi) Drug Information Journal - September 2007 - Table of Contents (Page xii) Drug Information Journal - September 2007 - Biomarker Editorial: The Many Lives of the Biomarker (Page 551) Drug Information Journal - September 2007 - Biomarker Editorial: The Many Lives of the Biomarker (Page 552) Drug Information Journal - September 2007 - Biomarker Editorial: The Many Lives of the Biomarker (Page 553) Drug Information Journal - September 2007 - Biomarker Editorial: The Many Lives of the Biomarker (Page 554) Drug Information Journal - September 2007 - Implementation of a Biomarker Into Drug Development: Example of Identifying the Right Imaging “Tool” for an Oncology Study (Page 555) Drug Information Journal - September 2007 - Implementation of a Biomarker Into Drug Development: Example of Identifying the Right Imaging “Tool” for an Oncology Study (Page 556) Drug Information Journal - September 2007 - Implementation of a Biomarker Into Drug Development: Example of Identifying the Right Imaging “Tool” for an Oncology Study (Page 557) Drug Information Journal - September 2007 - Implementation of a Biomarker Into Drug Development: Example of Identifying the Right Imaging “Tool” for an Oncology Study (Page 558) Drug Information Journal - September 2007 - Implementation of a Biomarker Into Drug Development: Example of Identifying the Right Imaging “Tool” for an Oncology Study (Page 559) Drug Information Journal - September 2007 - Implementation of a Biomarker Into Drug Development: Example of Identifying the Right Imaging “Tool” for an Oncology Study (Page 560) Drug Information Journal - September 2007 - Imaging Biomarker Applications in Oncology Drug Development (Page 561) Drug Information Journal - September 2007 - Imaging Biomarker Applications in Oncology Drug Development (Page 562) Drug Information Journal - September 2007 - Imaging Biomarker Applications in Oncology Drug Development (Page 563) Drug Information Journal - September 2007 - Imaging Biomarker Applications in Oncology Drug Development (Page 564) Drug Information Journal - September 2007 - Imaging Biomarker Applications in Oncology Drug Development (Page 565) Drug Information Journal - September 2007 - Imaging Biomarker Applications in Oncology Drug Development (Page 566) Drug Information Journal - September 2007 - Imaging Biomarker Applications in Oncology Drug Development (Page 567) Drug Information Journal - September 2007 - Imaging Biomarker Applications in Oncology Drug Development (Page 568) Drug Information Journal - September 2007 - Imaging Biomarker Applications in Oncology Drug Development (Page 569) Drug Information Journal - September 2007 - Imaging Biomarker Applications in Oncology Drug Development (Page 570) Drug Information Journal - September 2007 - Imaging Biomarker Applications in Oncology Drug Development (Page 571) Drug Information Journal - September 2007 - Imaging Biomarker Applications in Oncology Drug Development (Page 572) Drug Information Journal - September 2007 - Molecular Biomarkers (Page 573) Drug Information Journal - September 2007 - Molecular Biomarkers (Page 574) Drug Information Journal - September 2007 - Molecular Biomarkers (Page 575) Drug Information Journal - September 2007 - Molecular Biomarkers (Page 576) Drug Information Journal - September 2007 - Molecular Biomarkers (Page 577) Drug Information Journal - September 2007 - Molecular Biomarkers (Page 578) Drug Information Journal - September 2007 - Molecular Biomarkers (Page 579) Drug Information Journal - September 2007 - Molecular Biomarkers (Page 580) Drug Information Journal - September 2007 - Molecular Biomarkers (Page 581) Drug Information Journal - September 2007 - Molecular Biomarkers (Page 582) Drug Information Journal - September 2007 - Molecular Biomarkers (Page 583) Drug Information Journal - September 2007 - Molecular Biomarkers (Page 584) Drug Information Journal - September 2007 - Molecular Biomarkers (Page 585) Drug Information Journal - September 2007 - Molecular Biomarkers (Page 586) Drug Information Journal - September 2007 - A Regulatory Perspective on Validation of Surrogate Endpoints (Page 587) Drug Information Journal - September 2007 - A Regulatory Perspective on Validation of Surrogate Endpoints (Page 588) Drug Information Journal - September 2007 - A Regulatory Perspective on Validation of Surrogate Endpoints (Page 589) Drug Information Journal - September 2007 - A Regulatory Perspective on Validation of Surrogate Endpoints (Page 590) Drug Information Journal - September 2007 - A Regulatory Perspective on Validation of Surrogate Endpoints (Page 591) Drug Information Journal - September 2007 - A Regulatory Perspective on Validation of Surrogate Endpoints (Page 592) Drug Information Journal - September 2007 - A Regulatory Perspective on Validation of Surrogate Endpoints (Page 593) Drug Information Journal - September 2007 - A Regulatory Perspective on Validation of Surrogate Endpoints (Page 594) Drug Information Journal - September 2007 - Interrater Reliability for Multiple Raters in Clinical Trials of Ordinal Scale (Page 595) Drug Information Journal - September 2007 - Interrater Reliability for Multiple Raters in Clinical Trials of Ordinal Scale (Page 596) Drug Information Journal - September 2007 - Interrater Reliability for Multiple Raters in Clinical Trials of Ordinal Scale (Page 597) Drug Information Journal - September 2007 - Interrater Reliability for Multiple Raters in Clinical Trials of Ordinal Scale (Page 598) Drug Information Journal - September 2007 - Interrater Reliability for Multiple Raters in Clinical Trials of Ordinal Scale (Page 599) Drug Information Journal - September 2007 - Interrater Reliability for Multiple Raters in Clinical Trials of Ordinal Scale (Page 600) Drug Information Journal - September 2007 - Interrater Reliability for Multiple Raters in Clinical Trials of Ordinal Scale (Page 601) Drug Information Journal - September 2007 - Interrater Reliability for Multiple Raters in Clinical Trials of Ordinal Scale (Page 602) Drug Information Journal - September 2007 - Interrater Reliability for Multiple Raters in Clinical Trials of Ordinal Scale (Page 603) Drug Information Journal - September 2007 - Interrater Reliability for Multiple Raters in Clinical Trials of Ordinal Scale (Page 604) Drug Information Journal - September 2007 - Interrater Reliability for Multiple Raters in Clinical Trials of Ordinal Scale (Page 605) Drug Information Journal - September 2007 - Interrater Reliability for Multiple Raters in Clinical Trials of Ordinal Scale (Page 606) Drug Information Journal - September 2007 - Notes on Test Equality in Stratified Noncompliance Randomized Trials (Page 607) Drug Information Journal - September 2007 - Notes on Test Equality in Stratified Noncompliance Randomized Trials (Page 608) Drug Information Journal - September 2007 - Notes on Test Equality in Stratified Noncompliance Randomized Trials (Page 609) Drug Information Journal - September 2007 - Notes on Test Equality in Stratified Noncompliance Randomized Trials (Page 610) Drug Information Journal - September 2007 - Notes on Test Equality in Stratified Noncompliance Randomized Trials (Page 611) Drug Information Journal - September 2007 - Notes on Test Equality in Stratified Noncompliance Randomized Trials (Page 612) Drug Information Journal - September 2007 - Notes on Test Equality in Stratified Noncompliance Randomized Trials (Page 613) Drug Information Journal - September 2007 - Notes on Test Equality in Stratified Noncompliance Randomized Trials (Page 614) Drug Information Journal - September 2007 - Notes on Test Equality in Stratified Noncompliance Randomized Trials (Page 615) Drug Information Journal - September 2007 - Notes on Test Equality in Stratified Noncompliance Randomized Trials (Page 616) Drug Information Journal - September 2007 - Notes on Test Equality in Stratified Noncompliance Randomized Trials (Page 617) Drug Information Journal - September 2007 - Notes on Test Equality in Stratified Noncompliance Randomized Trials (Page 618) Drug Information Journal - September 2007 - Sex Differences in QT Interval Variability and Implication on Sample Size of Thorough QT Study (Page 619) Drug Information Journal - September 2007 - Sex Differences in QT Interval Variability and Implication on Sample Size of Thorough QT Study (Page 620) Drug Information Journal - September 2007 - Sex Differences in QT Interval Variability and Implication on Sample Size of Thorough QT Study (Page 621) Drug Information Journal - September 2007 - Sex Differences in QT Interval Variability and Implication on Sample Size of Thorough QT Study (Page 622) Drug Information Journal - September 2007 - Sex Differences in QT Interval Variability and Implication on Sample Size of Thorough QT Study (Page 623) Drug Information Journal - September 2007 - Sex Differences in QT Interval Variability and Implication on Sample Size of Thorough QT Study (Page 624) Drug Information Journal - September 2007 - Sex Differences in QT Interval Variability and Implication on Sample Size of Thorough QT Study (Page 625) Drug Information Journal - September 2007 - Sex Differences in QT Interval Variability and Implication on Sample Size of Thorough QT Study (Page 626) Drug Information Journal - September 2007 - Sex Differences in QT Interval Variability and Implication on Sample Size of Thorough QT Study (Page 627) Drug Information Journal - September 2007 - Sex Differences in QT Interval Variability and Implication on Sample Size of Thorough QT Study (Page 628) Drug Information Journal - September 2007 - Some Comments on Improving Collaboration Skills of the Statistician on a Drug Development Team (Page 629) Drug Information Journal - September 2007 - Some Comments on Improving Collaboration Skills of the Statistician on a Drug Development Team (Page 630) Drug Information Journal - September 2007 - Some Comments on Improving Collaboration Skills of the Statistician on a Drug Development Team (Page 631) Drug Information Journal - September 2007 - Some Comments on Improving Collaboration Skills of the Statistician on a Drug Development Team (Page 632) Drug Information Journal - September 2007 - Using Data Mining to Predict Safety Actions From FDA Adverse Event Reporting System Data (Page 633) Drug Information Journal - September 2007 - Using Data Mining to Predict Safety Actions From FDA Adverse Event Reporting System Data (Page 634) Drug Information Journal - September 2007 - Using Data Mining to Predict Safety Actions From FDA Adverse Event Reporting System Data (Page 635) Drug Information Journal - September 2007 - Using Data Mining to Predict Safety Actions From FDA Adverse Event Reporting System Data (Page 636) Drug Information Journal - September 2007 - Using Data Mining to Predict Safety Actions From FDA Adverse Event Reporting System Data (Page 637) Drug Information Journal - September 2007 - Using Data Mining to Predict Safety Actions From FDA Adverse Event Reporting System Data (Page 638) Drug Information Journal - September 2007 - Using Data Mining to Predict Safety Actions From FDA Adverse Event Reporting System Data (Page 639) Drug Information Journal - September 2007 - Using Data Mining to Predict Safety Actions From FDA Adverse Event Reporting System Data (Page 640) Drug Information Journal - September 2007 - Using Data Mining to Predict Safety Actions From FDA Adverse Event Reporting System Data (Page 641) Drug Information Journal - September 2007 - Using Data Mining to Predict Safety Actions From FDA Adverse Event Reporting System Data (Page 642) Drug Information Journal - September 2007 - Using Data Mining to Predict Safety Actions From FDA Adverse Event Reporting System Data (Page 643) Drug Information Journal - September 2007 - Using Data Mining to Predict Safety Actions From FDA Adverse Event Reporting System Data (Page 644) Drug Information Journal - September 2007 - The Demographic, Practice, and Prescribing Characteristics of US Clinical Investigators (Page 645) Drug Information Journal - September 2007 - The Demographic, Practice, and Prescribing Characteristics of US Clinical Investigators (Page 646) Drug Information Journal - September 2007 - The Demographic, Practice, and Prescribing Characteristics of US Clinical Investigators (Page 647) Drug Information Journal - September 2007 - The Demographic, Practice, and Prescribing Characteristics of US Clinical Investigators (Page 648) Drug Information Journal - September 2007 - The Demographic, Practice, and Prescribing Characteristics of US Clinical Investigators (Page 649) Drug Information Journal - September 2007 - The Demographic, Practice, and Prescribing Characteristics of US Clinical Investigators (Page 650) Drug Information Journal - September 2007 - The Demographic, Practice, and Prescribing Characteristics of US Clinical Investigators (Page 651) Drug Information Journal - September 2007 - The Demographic, Practice, and Prescribing Characteristics of US Clinical Investigators (Page 652) Drug Information Journal - September 2007 - The December Effect in FDA Drug Approvals: Assessing the Submissions Echo Hypothesis (Page 653) Drug Information Journal - September 2007 - The December Effect in FDA Drug Approvals: Assessing the Submissions Echo Hypothesis (Page 654) Drug Information Journal - September 2007 - The December Effect in FDA Drug Approvals: Assessing the Submissions Echo Hypothesis (Page 655) Drug Information Journal - September 2007 - The December Effect in FDA Drug Approvals: Assessing the Submissions Echo Hypothesis (Page 656) Drug Information Journal - September 2007 - The December Effect in FDA Drug Approvals: Assessing the Submissions Echo Hypothesis (Page 657) Drug Information Journal - September 2007 - The December Effect in FDA Drug Approvals: Assessing the Submissions Echo Hypothesis (Page 658) Drug Information Journal - September 2007 - The December Effect in FDA Drug Approvals: Assessing the Submissions Echo Hypothesis (Page 659) Drug Information Journal - September 2007 - The December Effect in FDA Drug Approvals: Assessing the Submissions Echo Hypothesis (Page 660) Drug Information Journal - September 2007 - The December Effect in FDA Drug Approvals: Assessing the Submissions Echo Hypothesis (Page 661) Drug Information Journal - September 2007 - The December Effect in FDA Drug Approvals: Assessing the Submissions Echo Hypothesis (Page 662) Drug Information Journal - September 2007 - The December Effect in FDA Drug Approvals: Assessing the Submissions Echo Hypothesis (Page 663) Drug Information Journal - September 2007 - The December Effect in FDA Drug Approvals: Assessing the Submissions Echo Hypothesis (Page 664) Drug Information Journal - September 2007 - The December Effect in FDA Drug Approvals: Assessing the Submissions Echo Hypothesis (Page 665) Drug Information Journal - September 2007 - The December Effect in FDA Drug Approvals: Assessing the Submissions Echo Hypothesis (Page 666) Drug Information Journal - September 2007 - The December Effect in FDA Drug Approvals: Assessing the Submissions Echo Hypothesis (Page 667) Drug Information Journal - September 2007 - The December Effect in FDA Drug Approvals: Assessing the Submissions Echo Hypothesis (Page 668) Drug Information Journal - September 2007 - The December Effect in FDA Drug Approvals: Assessing the Submissions Echo Hypothesis (Page 669) Drug Information Journal - September 2007 - The December Effect in FDA Drug Approvals: Assessing the Submissions Echo Hypothesis (Page 670) Drug Information Journal - September 2007 - The December Effect in FDA Drug Approvals: Assessing the Submissions Echo Hypothesis (Page 671) Drug Information Journal - September 2007 - The December Effect in FDA Drug Approvals: Assessing the Submissions Echo Hypothesis (Page 672) Drug Information Journal - September 2007 - How to Improve Complex Drug Development? A Critical Review of FDA Advisory Meetings (Page 673) Drug Information Journal - September 2007 - How to Improve Complex Drug Development? A Critical Review of FDA Advisory Meetings (Page 674) Drug Information Journal - September 2007 - How to Improve Complex Drug Development? A Critical Review of FDA Advisory Meetings (Page 675) Drug Information Journal - September 2007 - How to Improve Complex Drug Development? A Critical Review of FDA Advisory Meetings (Page 676) Drug Information Journal - September 2007 - How to Improve Complex Drug Development? A Critical Review of FDA Advisory Meetings (Page 677) Drug Information Journal - September 2007 - How to Improve Complex Drug Development? A Critical Review of FDA Advisory Meetings (Page 678) Drug Information Journal - September 2007 - How to Improve Complex Drug Development? A Critical Review of FDA Advisory Meetings (Page 679) Drug Information Journal - September 2007 - How to Improve Complex Drug Development? A Critical Review of FDA Advisory Meetings (Page 680) Drug Information Journal - September 2007 - How to Improve Complex Drug Development? A Critical Review of FDA Advisory Meetings (Page 681) Drug Information Journal - September 2007 - How to Improve Complex Drug Development? A Critical Review of FDA Advisory Meetings (Page 682) Drug Information Journal - September 2007 - How to Improve Complex Drug Development? A Critical Review of FDA Advisory Meetings (Page 683) Drug Information Journal - September 2007 - How to Improve Complex Drug Development? A Critical Review of FDA Advisory Meetings (Page 684) Drug Information Journal - September 2007 - A Statistician’s Viewpoint of Responders in the Treatment of Neuropathic Pain (Page 685) Drug Information Journal - September 2007 - A Statistician’s Viewpoint of Responders in the Treatment of Neuropathic Pain (Page 686) Drug Information Journal - September 2007 - A Statistician’s Viewpoint of Responders in the Treatment of Neuropathic Pain (Page 687) Drug Information Journal - September 2007 - A Statistician’s Viewpoint of Responders in the Treatment of Neuropathic Pain (Page 688) Drug Information Journal - September 2007 - A Statistician’s Viewpoint of Responders in the Treatment of Neuropathic Pain (Page 689) Drug Information Journal - September 2007 - A Statistician’s Viewpoint of Responders in the Treatment of Neuropathic Pain (Page 690) Drug Information Journal - September 2007 - A Statistician’s Viewpoint of Responders in the Treatment of Neuropathic Pain (Page Cover3) Drug Information Journal - September 2007 - A Statistician’s Viewpoint of Responders in the Treatment of Neuropathic Pain (Page Cover4) http://www.nxtbookMEDIA.com
For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.